Medico Remedies Ltd Locks at Lower Circuit With 20.0% Loss — Sellers Queue, No Buyers in Sight

32 minutes ago
share
Share Via
At Rs 26.00, sellers were still queuing — but there were no buyers willing to take the other side. Medico Remedies Ltd locked at its lower circuit of 20.0% on 25 Sep 2026, with unfilled sell orders and a frozen price.
Medico Remedies Ltd Locks at Lower Circuit With 20.0% Loss — Sellers Queue, No Buyers in Sight

Circuit Event and Unfilled Supply

The stock hit its maximum allowed daily loss of 20.0%, closing at Rs 26.00, the lower circuit price for the day. This 20% price band is the widest permitted for the session, signalling a severe price correction. The trading session was characterised by unfilled supply — sellers were lined up to exit positions, but buyers were absent, causing the price to freeze at the floor. The total traded volume stood at 23.38 lakh shares, with a turnover of Rs 6.51 crore, but much of the supply remained unexecuted due to the circuit lock. This scenario is typical for micro-cap stocks like Medico Remedies Ltd, where liquidity constraints exacerbate exit difficulties. Medico Remedies Ltd’s market capitalisation is Rs 271 crore, placing it firmly in the micro-cap segment.

Delivery and Volume Analysis

Delivery volumes on 24 Sep fell sharply by 48.69% compared to the 5-day average, registering 1.02 lakh shares. This decline in delivery volume suggests that the selling pressure on the lower circuit day was not driven by genuine liquidation of holdings but possibly by speculative short-selling or intraday trades. On a lower circuit day, rising delivery volumes would indicate holders offloading actual shares, signalling capitulation. However, the falling delivery volume here points to a different dynamic — the sellers may be attempting to exit but are constrained by the lack of buyers, and the actual transfer of shares is limited. Medico Remedies Ltd’s total traded volume was moderately high, but the delivery data reveals a nuanced picture of selling quality. Medico Remedies Ltd’s liquidity profile allows a trade size of approximately Rs 0.02 crore based on 2% of the 5-day average traded value, indicating limited room for large exits without impacting price.

Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!

  • - Hidden turnaround gem
  • - Solid fundamentals confirmed
  • - Large Cap opportunity

Discover This Hidden Gem →

Intraday Price Action

The stock opened directly at the lower circuit price of Rs 26.00 and remained locked there throughout the session, with no intraday recovery or upward movement. The intraday volatility was calculated at 18.32%, reflecting the weighted average price’s proximity to the low price. This lack of price range indicates that the selling pressure was immediate and sustained, with no buyers stepping in to support the price at any point. The weighted average price being close to the low price further confirms that most trades occurred near the circuit floor, reinforcing the narrative of persistent unfilled supply. Medico Remedies Ltd’s inability to trade above the circuit price throughout the day highlights the severity of the selling pressure and the absence of demand. Does the intraday price action suggest a capitulation phase or a prolonged liquidity trap?

Moving Averages and Trend Context

Medico Remedies Ltd is trading below all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning confirms a sustained downtrend that preceded the lower circuit event. The stock’s consistent failure to hold above these averages signals weak investor sentiment and a lack of technical support. The circuit lock at the lower band merely accelerated an already established negative trend. Does the technical profile of Medico Remedies show any nearby support, or is more downside likely?

Liquidity and Exit Risk

As a micro-cap stock with a market capitalisation of Rs 271 crore, Medico Remedies Ltd faces significant liquidity constraints. The total turnover of Rs 6.51 crore on the circuit day, combined with a trade size limit of Rs 0.02 crore based on 2% of the 5-day average traded value, indicates that meaningful exits are difficult without further price impact. The lower circuit lock compounds this problem by freezing the price at the floor, effectively trapping sellers who cannot find buyers. This creates a risk of multi-day circuit locks if selling pressure persists, as the supply remains unfilled and liquidity dries up. With unfilled sell orders at Rs 26.00 and near-zero liquidity, how deep is the exit problem for Medico Remedies and what would need to change for normal trading to resume?

Why settle for Medico Remedies Ltd? SwitchER evaluates this Pharmaceuticals & Biotechnology micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!

  • - Comprehensive evaluation done
  • - Superior opportunities identified
  • - Smart switching enabled

Discover Superior Stocks →

Fundamental Context

Medico Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, a space often characterised by volatility and regulatory sensitivity. The stock has been on a downward trajectory for six consecutive sessions, accumulating a loss of 28.45% over this period. Its underperformance relative to the sector, which declined by only 0.01% on the same day, and the Sensex’s gain of 0.09%, underscores the stock-specific nature of the sell-off rather than broader market weakness.

Conclusion: Severity and Liquidity Caveats

The 20.0% single-day loss culminating in a lower circuit lock for Medico Remedies Ltd reflects a severe episode of selling pressure compounded by limited buyer interest. The falling delivery volumes suggest speculative selling rather than outright capitulation, but the absence of demand at the circuit floor highlights the liquidity exit risk inherent in micro-cap stocks. The technical backdrop of trading below all moving averages confirms the weakness, while the intraday price action shows no relief from the selling pressure. After a 20.0% single-day loss at lower circuit, is Medico Remedies approaching oversold territory or does the selling pressure have further to run? The complete analysis weighs the data.

Liquidity and Exit Risk Caution

Micro-cap stocks like Medico Remedies Ltd face amplified exit risk when locked at lower circuit. Sellers cannot exit easily due to unfilled supply and limited buyer interest, potentially resulting in multi-day circuit locks. Investors should be aware of the challenges in trading such stocks during extreme price moves.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News